Book Appointment
Subscribe to out newsletter today to receive latest news administrate cost effective for tactical data.
TreatmentsWhen facing cancer, you want a trusted doctor who offers more than just basic treatments. You need a full suite of services from an experienced oncologist who can provide world-class, personalized care.
A lack of comprehensive services and a truly specialized doctor can leave you feeling unsupported and alone, forcing you to search for additional resources while you should be focused on healing.
Dr. Sandip Ganguly’s Comprehensive Oncology Services are built to provide a complete solution for Cancer Treatment in Kolkata. He delivers expert care with over 15 years of specialized oncology experience, offering a wide range of cutting-edge therapies and supportive programs all in one place. You can be confident in a coordinated, compassionate, and robust support system.
Here are the comprehensive oncology services:
Lung cancer treatment requires a multidisciplinary approach combining advanced diagnostic tools and personalized therapy. Dr. Ganguly utilizes modern molecular testing to identify specific genetic mutations, allowing for targeted therapies and immunotherapy options that significantly improve patient outcomes. The lung cancer treatment protocol includes comprehensive staging through imaging studies, followed by customized treatment plans that may involve chemotherapy, radiation therapy, targeted agents like erlotinib for ALK-rearranged cases, and cutting-edge immunotherapy drugs.
For patients with advanced non-small cell lung cancer, particularly those with EGFR mutations, Dr. Ganguly employs combination therapies including amivantamab plus chemotherapy, which has shown promising results in clinical trials. The treatment approach emphasizes both disease control and quality of life management, ensuring patients receive supportive care throughout their treatment journey.
Stomach cancer management involves sophisticated systemic therapy approaches tailored to each patient’s specific tumor characteristics and overall health status. Dr. Ganguly specializes in gastrointestinal malignancies, utilizing advanced chemotherapy regimens and targeted therapies to achieve optimal outcomes. Treatment typically begins with comprehensive staging and molecular profiling to determine the most effective therapeutic strategy, whether neoadjuvant, adjuvant, or palliative care.
The treatment protocol includes careful monitoring of dihydropyrimidine dehydrogenase gene mutations to minimize toxicity from 5-fluorouracil-based chemotherapy regimens commonly used in gastrointestinal cancers. Dr. Ganguly’s approach emphasizes minimizing treatment-related side effects while maximizing therapeutic efficacy through personalized medicine approaches.
Cervical cancer treatment combines multimodal therapy approaches designed to eliminate cancer cells while preserving fertility when possible. Dr. Ganguly’s expertise in gynecological malignancies includes comprehensive treatment planning that may involve chemotherapy, radiation therapy, and targeted agents. Early-stage cervical cancer treatment focuses on curative approaches, while advanced cases require systemic therapy combined with supportive care measures.
The treatment strategy incorporates the latest advances in immunotherapy and targeted therapy, particularly for patients with recurrent or metastatic disease. Dr. Ganguly emphasizes the importance of multidisciplinary care coordination, ensuring patients receive optimal surgical, medical, and radiation oncology input throughout their treatment course.
Hepatobiliary cancers, including liver and bile duct cancers, require specialized treatment approaches given their complex anatomical location and aggressive nature. Dr. Ganguly’s experience in treating hepatocellular carcinoma includes utilizing real-world data to optimize treatment outcomes, as demonstrated in the OREIOS study examining survival patterns in unresectable cases. Treatment options include systemic therapy, targeted agents, and immunotherapy depending on the specific tumor type and stage.
The management strategy focuses on controlling disease progression while maintaining quality of life through comprehensive supportive care measures. Advanced treatment options may include combination therapies and participation in clinical trials to access the most cutting-edge therapeutic approaches available.
Breast cancer treatment at Dr. Ganguly’s practice emphasizes personalized medicine approaches using comprehensive molecular profiling to guide therapy selection. His expertise covers all subtypes of breast cancer, from hormone receptor-positive to triple-negative cases, utilizing appropriate targeted therapies, chemotherapy, and hormone treatments. Treatment planning involves careful consideration of tumor biology, patient preferences, and potential long-term outcomes.
Advanced cases benefit from Dr. Ganguly’s experience with immunotherapy and targeted agents, including CDK4/6 inhibitors, HER2-targeted therapies, and novel immunotherapy combinations. The treatment approach includes careful toxicity monitoring and supportive care measures to ensure patients can complete their planned therapy while maintaining optimal quality of life throughout treatment.
Gynecological cancers encompass a diverse group of malignancies requiring specialized expertise in systemic therapy approaches. Dr. Ganguly’s focus on gynecological malignancies includes ovarian, endometrial, and cervical cancers, with particular expertise in ovarian germ cell tumors management. Treatment protocols emphasize the importance of early detection and aggressive treatment while managing potential fertility concerns in younger patients.
The approach includes comprehensive tumor board discussions to ensure optimal treatment planning, incorporating surgery, chemotherapy, and targeted therapy as appropriate. Dr. Ganguly’s research contributions include studies on ovarian cancer management, particularly focusing on PARP inhibitor therapy and bevacizumab combinations in patients with BRCA mutations or homologous recombination deficiency.
Prostate cancer treatment involves hormone therapy approaches combined with advanced systemic treatments for metastatic disease. Dr. Ganguly’s expertise includes managing both localized and advanced prostate cancer cases, utilizing hormone therapy protocols and newer agents like abiraterone and enzalutamide for castration-resistant disease. Treatment planning considers patient age, comorbidities, and disease extent to optimize therapeutic outcomes.
Advanced prostate cancer management includes careful monitoring of treatment response and toxicity, with supportive care measures to maintain quality of life. The treatment approach may incorporate combination therapies and clinical trial participation for patients with resistant disease, ensuring access to the most current therapeutic advances.
Head and neck cancer treatment requires careful coordination between multiple specialties to achieve optimal outcomes while preserving function and appearance. Dr. Ganguly’s multidisciplinary approach includes comprehensive treatment planning incorporating chemotherapy, targeted therapy, and immunotherapy options. Treatment protocols are designed to maximize disease control while minimizing impact on speech, swallowing, and quality of life.
The management strategy includes careful assessment of tumor location and extent, with treatment plans tailored to preserve critical functions whenever possible. Advanced cases benefit from Dr. Ganguly’s experience with combination therapies and clinical trial access, ensuring patients receive the most effective treatments available for their specific tumor type and stage.
Colorectal cancer treatment utilizes advanced molecular testing to guide personalized therapy selection, including analysis of microsatellite instability and specific genetic mutations. Dr. Ganguly’s expertise in gastrointestinal malignancies includes comprehensive management of both colon and rectal cancers, utilizing appropriate chemotherapy regimens, targeted agents, and immunotherapy when indicated. Treatment planning emphasizes achieving cure in early-stage disease and optimal disease control in advanced cases.
The therapeutic approach includes careful consideration of genetic factors affecting drug metabolism, particularly dihydropyrimidine dehydrogenase mutations that influence 5-fluorouracil toxicity. Dr. Ganguly’s research contributions include studies examining the correlation between genetic variations and chemotherapy toxicity, leading to more personalized and safer treatment approaches.
Pancreatic cancer represents one of the most challenging malignancies, requiring aggressive treatment approaches and comprehensive supportive care. Dr. Ganguly’s experience includes managing both localized and metastatic pancreatic adenocarcinoma, utilizing combination chemotherapy regimens and participating in clinical trials to access novel therapeutic approaches. Treatment focuses on disease control and symptom management given the aggressive nature of this malignancy.
The management strategy includes careful attention to nutritional support, pain control, and quality of life measures throughout treatment. Dr. Ganguly’s research contributions include case reports of rare pancreatic cancer presentations, contributing to the medical literature’s understanding of unusual disease manifestations and treatment approaches.
Gallbladder cancer treatment requires specialized expertise given its rarity and aggressive behavior. Dr. Ganguly’s approach to hepatobiliary malignancies includes comprehensive staging and treatment planning for gallbladder cancer cases, utilizing appropriate systemic therapy options based on disease extent and patient performance status. Treatment protocols emphasize achieving disease control while maintaining quality of life through effective supportive care measures.
The therapeutic strategy includes consideration of both curative and palliative approaches depending on disease stage at presentation. Advanced cases may benefit from participation in clinical trials and access to novel therapeutic agents through Dr. Ganguly’s involvement in research initiatives.
Liver cancer treatment requires careful assessment of underlying liver function and comprehensive treatment planning incorporating multiple therapeutic modalities. Dr. Ganguly’s expertise in hepatocellular carcinoma includes participation in studies examining real-world outcomes in unresectable cases, contributing to improved understanding of optimal treatment approaches. Treatment options include systemic therapy, targeted agents, and immunotherapy depending on liver function and disease characteristics.
The management approach emphasizes preserving liver function while achieving disease control through carefully selected treatment regimens. Dr. Ganguly’s experience includes managing complex cases requiring multidisciplinary coordination between medical oncology, hepatology, and surgical specialties.
Ovarian cancer treatment utilizes comprehensive molecular profiling to guide personalized therapy selection, including BRCA mutation testing and homologous recombination deficiency analysis. Dr. Ganguly’s expertise includes managing both epithelial ovarian cancer and rare subtypes like germ cell tumors, with research contributions examining multidisciplinary management approaches. Treatment protocols emphasize achieving cure in early-stage disease and optimal disease control in advanced cases through combination approaches.
The therapeutic strategy includes PARP inhibitor maintenance therapy for appropriate patients and careful management of treatment-related toxicities. Dr. Ganguly’s research experience includes studies on maintenance therapy combinations and real-world outcomes in patients with genetic predispositions to ovarian cancer.
Sarcoma treatment requires specialized expertise given the diverse subtypes and varying treatment approaches needed for different histologies. Dr. Ganguly’s experience in treating solid tumors includes sarcoma management, utilizing appropriate chemotherapy regimens, targeted therapy, and immunotherapy options based on specific sarcoma subtype and molecular characteristics. Treatment planning emphasizes achieving local and systemic disease control while preserving function.
The management approach includes comprehensive staging and treatment planning incorporating surgery, radiation therapy, and systemic treatments as appropriate. Advanced cases benefit from access to clinical trials and novel therapeutic approaches through Dr. Ganguly’s research involvement and institutional resources.
Bone tumor treatment requires multidisciplinary coordination between medical oncology, orthopedic surgery, and radiation oncology to achieve optimal outcomes. Dr. Ganguly’s approach includes comprehensive treatment planning for both primary bone tumors and metastatic disease to bone, utilizing appropriate systemic therapy options and supportive care measures. Treatment protocols emphasize disease control while preserving mobility and quality of life.
The therapeutic strategy includes careful attention to pain management, bone health, and prevention of skeletal complications through appropriate use of bone-modifying agents. Treatment planning considers both curative intent in primary cases and palliative approaches for metastatic bone disease.
Brain tumor treatment requires specialized approaches given the unique challenges of treating central nervous system malignancies. Dr. Ganguly’s solid tumor expertise extends to brain tumor management, utilizing systemic therapy options that can effectively cross the blood-brain barrier and achieve meaningful disease control. Treatment planning emphasizes coordinating care with neurosurgical and radiation oncology specialists.
The management approach includes careful consideration of treatment-related side effects on neurological function and quality of life. Advanced cases may benefit from participation in clinical trials examining novel therapeutic approaches specifically designed for central nervous system malignancies.
Skin cancer treatment varies significantly based on histologic subtype, with melanoma requiring particularly specialized management approaches. Dr. Ganguly’s expertise includes treating melanoma and other skin cancers, utilizing immunotherapy and targeted therapy options that have revolutionized outcomes in advanced cases. Treatment protocols emphasize achieving cure in early-stage disease and optimal disease control in advanced cases.
The therapeutic approach includes comprehensive staging and treatment planning incorporating surgery, systemic therapy, and radiation therapy as appropriate. Dr. Ganguly’s experience with immunotherapy protocols provides patients access to the most effective treatments available for advanced melanoma and other skin cancers.
Blood cancer treatment encompasses a diverse group of hematologic malignancies requiring specialized expertise in systemic therapy approaches. Dr. Ganguly’s experience includes treating various blood cancers including lymphomas and leukemias, utilizing appropriate chemotherapy regimens, targeted therapy, and immunotherapy options. Treatment planning emphasizes achieving remission while managing treatment-related toxicities through comprehensive supportive care measures.
The management strategy includes consideration of novel therapeutic approaches including CAR-T cell therapy for appropriate patients and participation in clinical trials to access cutting-edge treatments. Dr. Ganguly’s comprehensive oncology background ensures patients receive optimal care coordination throughout their treatment journey.
